Matt Rappaport

Matthew Rappaport

Co-Founder, Managing Director

Matthew Rappaport co-founded IP Checkups® in 2004 after spending several years working with patent and text analytic software tools to develop a proprietary methodology for assessing the relationships between competitive patent portfolios. He has rapidly built IP Checkups into a pre-eminent source for quantitative and qualitative analysis and interpretation of patent portfolios.

Mr. Rappaport has provided competitive patent landscape analyses, IP portfolio strategy and development services, custom patent searching and analysis and created customized patent databases for large corporate clients, a variety of mid-sized biotech, pharma, medical device and cleantech companies, start-ups, venture capital, private equity, and hedge funds. Through its patent-centric approach to competitive technology markets, IP Checkups enhances companies’ understanding of the intellectual assets that underlie key products and R&D initiatives.

Matthew leads interdepartmental workshops that help companies improve IP strategies and identify white space and design around opportunities to help companies generate superior returns on investment in a variety of fields.

Mr. Rappaport has been a speaker at several conferences dealing with patent analytics, patent strategy, and the importance of patents to investors. He is a member of the IAM 250, Intellectual Asset Magazine’s list of the world’s leading IP strategists. He also serves as Virtual Professional-in-Residence at the University of Hawaii, Shidler College of Business.

Irving Rappaport

Irving S. Rappaport, Esq.

Patent Attorney/Inventor/Entrepreneur
Co-Founder IP Checkups

Irving Rappaport has been a licensed patent attorney for over 35 years. He has served as the head of IP departments in all of his positions and consistently allied himself with emerging technology companies. This is evidenced by his career which began at Raytheon in the late 1960′s. From there, Irving led Medtronic’s Intellectual Property program in the early 1970′s and went on to head Data General’s IP department in the late 70′s. He was then recruited by Bally-Midway to chase Pac-Man clones during the first video game revolution and was eventually brought to Silicon Valley as Associate General Counsel for Intellectual Property and Licensing at Apple Computer, where he built Apple’s IP department from 1984-90. Irving also spent time consulting for Intel and was VP and Associate General Counsel for IP and Licensing at National Semiconductor in the early 1990′s.

With a talent for spotting up and coming trends, Irving identified the need to create tools for evaluating and manipulating patents that would keep the field of patent analysis current with the high tech explosion. Thus in 1992, Irving co-founded SmartPatents, Inc., a start up focused on converting paper patents into an electronic format. This enabled people to begin to develop tools aimed at assessing and manipulating patents in ways never before possible. In 1996 SmartPatents began developing a powerful software platform used for evaluating and assessing entire patent portfolios in their competitive landscapes. In 1998 SmartPatents changed its name to Aurigin Systems, Inc. At the time of its sale in 2002 the company had over 100 Fortune 1000 companies as customers. Irving is a co-inventor on 16 U.S. patents that underlie the Aureka® software, which is considered the pre-eminent platform in its class.

Mark Garner

Mark Garner

Director of Operations

Mark Garner manages IP Checkups’ technology infrastructure of tools and databases containing millions of patents and publications. He developed the underlying functionality and architechture of the PatentCAM software tool as well as for the CleanTech PatentEdge database. Mark’s deep understanding of patent information along with his mastery of Java, Perl and other tools enable him to enhance the quality and comprehensiveness of IP Checkups’ technology solutions related to text analytics, patent alerts, and managing IP portfolios. Mark has also overseen projects related to voice recognition, audio technologies and software systems integration.

Prior to joining IP Checkups in 2006, Mark spent five years as a professional audio and recording engineer for headlining acts and major outdoor festivals throughout the country. He earned a B.S. in Computer Science from the University of Oklahoma.
Dr. Kathryn Paisner, PhD

Dr. Kathryn Paisner, PhD

Director of Research, Analytics & Business Development

Kathryn Paisner joined IP Checkups in 2011 to co-manage the development, marketing and sales of the CleanTech PatentEdge solution. She also contributes her scientific expertise to IP Checkups’ boutique patent analytic and research services team, helping companies align their IP strategies with their business objectives.

Kathryn earned her PhD in Organic Chemistry at the University of Oregon, in the lab of Professor Kenneth M. Doxsee. While at Oregon from 2007-2011, Kathryn developed a patentable class of compounds (currently at the Innovation Disclosure stage), conducted the first experimental study of Resonance-Assisted Hydrogen Bonding–a process integral to enzyme activity and the development of biomimetic and medicinal technologies–and created a reliable solid-state thiourea synthon for use in crystal engineering. She also served as a project assistant at the Center for Advanced Technology in Education, where she worked with educators in Oregon and Mexico to develop a bilingual, web-based environmental science curriculum for middle school students in both countries.

A fashion designer whose clothing was exhibited at local shows in Eugene, Oregon, Kathryn also has worked with her electronic musician husband, Russ, in concert production. Kathryn earned her BA with College Honors at the University of California at Santa Cruz, where she majored in U.S. History and minored in Chemistry. Her senior thesis, More Appropriately Titled: Unsentimental Education, provided a socio-political interpretation of Gustave Flaubert’s literary achievements, in the context of mid-19th century France.

Steve Krawczyk, PHD

Senior Director of Research & Strategy

Steve Krawczyk joined IP Checkups in 2013 to co manage the development and operations of the life sciences IP consulting business segment. He contributes his experience in pharmaceutical research, development, commercialization and IP analytics to provide clients with an understanding of the competitive advantages manifested by their, or their competitors’ IP portfolios.

Steve earned his PhD in Medicinal Chemistry from the University of Michigan in 1989 in the lab of Professor Leroy Townsend. Steve’s research focused on the synthesis of antiviral nucleosides. Steve joined Gilead Sciences in 1989, working on adapting unnatural nucleoside analogs as synthons for the construction of antisense and triplex forming gene silencing agents and as antiviral agents. During this time, his work resulted in over 40 peer reviewed publications, patents and presentations.

Using the patent searching and analyses skills acquired leading medicinal chemistry initiatives, Steve joined the Gilead IP department as a patent searcher and analyst supporting product attorneys with patent and scientific literature searching to aid patent drafting and prosecution, as well as performing FTO and patentability searches. Additionally, Steve continued to advise project teams on design around strategies based on patent landscape and SAR analyses. He eventually became head of Patent Informatics in 2006 managing the patent search group and providing patent landscape searches in support of M&A and partnering diligence.

While at Gilead, Steve earned his MBA in 2008 through Golden Gate University, graduating with high honors. He is expecting to obtain his JD in 2014 from Santa Clara University, where he is Senior Production Editor of the Santa Clara Law High Tech Law Journal.

Bruce Resnick, PHD, Patent Agent

Senior Patent Analyst

Bruce Resnick joined IP Checkups in 2013. He has over thirty years of experience working for Fortune 100 companies as a research manager (Kodak and International Paper) and intellectual asset manager (Cargill). During that time he has helped bring numerous concepts to commercialization. He and his team of twenty scientists have won five awards for best product of the year from International Paper and Cargill.

As an Intellectual Asset Manager, Bruce has worked with numerous business entities to ensure they have maximized the value of their intellectual property by proper protection and subsequent value extraction. He also trained personnel on protection of trade secret to minimize intellectual property losses. Bruce has assisted inventors to understand the prior art and the competitive landscape and use that information to determine potential viability of research efforts and to draft claim language to provide maximum patent rights. He has assisted research managers to ensure that intellectual property activities align with business objectives. He has also worked with intellectual property attorneys and business personnel on various merger and acquisition opportunities.

For several years he was on the Board of directors for the Chemical Biological Radiological Team (CBRT) which comprised a group of 13 companies selected by the US Government to provide research needs for terror protection in light of 9/11.

He was editor of a book on Food Safety in the Series on Homeland Security published by John Wiley and Sons. He also was a contributor to the Intellectual Property Owners Association (IPOA) “Primer on Patent Searching”.
Bruce also has been a registered patent agent since 1994 and has prepared patent applications for large companies, universities, start-ups and individual inventors.

Bruce did post-doctoral research at the University of Illinois-Champaign Urbana studying the photobiology of nucleic acid studying under Professor Nelson Leonard. He received his doctorate in chemistry from New York University studying the photochemistry of cyclohexenones under Professor David Schuster.

He holds seventeen patents in diverse areas including food science and silver halide photographic films.